Literature DB >> 19301619

Ubiquitin-fusion protein system: a powerful tool for ectopic protein expression in mammalian cells.

Konstantin Matentzoglu1, Martin Scheffner.   

Abstract

Clonal cell lines stably expressing a protein of interest are frequently used in the characterization of the potential physiological functions of mammalian proteins, but the generation of such cell lines is laborious and time-consuming. Here, we made use of the fact that fusion proteins consisting of ubiquitin linked to the N terminus of a protein of interest are efficiently processed by ubiquitin-specific proteases into their respective free proteins within eukaryotic cells, and designed an expression system that allows easy and highly efficient selection of mammalian cells ectopically expressing a protein of interest.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19301619     DOI: 10.2144/000113023

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  4 in total

1.  Affinity proteomics to study endogenous protein complexes: pointers, pitfalls, preferences and perspectives.

Authors:  John LaCava; Kelly R Molloy; Martin S Taylor; Michal Domanski; Brian T Chait; Michael P Rout
Journal:  Biotechniques       Date:  2015-03-01       Impact factor: 1.993

2.  Characterization of L1-Ribonucleoprotein Particles.

Authors:  Martin S Taylor; John LaCava; Lixin Dai; Paolo Mita; Kathleen H Burns; Michael P Rout; Jef D Boeke
Journal:  Methods Mol Biol       Date:  2016

3.  Role of the ubiquitin ligase E6AP/UBE3A in controlling levels of the synaptic protein Arc.

Authors:  Simone Kühnle; Benedikt Mothes; Konstantin Matentzoglu; Martin Scheffner
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-13       Impact factor: 11.205

4.  A streamlined implementation of the glutamine synthetase-based protein expression system.

Authors:  Rachel Knox; Joanne E Nettleship; Veronica T Chang; Zhao Kun Hui; Ana Mafalda Santos; Nahid Rahman; Ling-Pei Ho; Raymond J Owens; Simon J Davis
Journal:  BMC Biotechnol       Date:  2013-09-24       Impact factor: 2.563

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.